RAVEN To Record New Album This Summer: 'The Stuff We've Got, It's Yet Another Step Ahead'

Why It Matters

The new record and tour represent a major revenue opportunity for Raven and its label, while the members' health recoveries provide a compelling story that can amplify fan engagement and media coverage.

Key Takeaways

• New Raven album slated for July‑August 2026 recording.
• Band plans extensive 2027 tour after album release.
• John Gallagher recovering from brain surgery, back on bass.
• Mark Gallagher completed ankle and knee replacement surgeries.
• EP \"Can’t Take Away The Fire\" sets tone for record.

Pulse Analysis

Raven, a seminal act of the New Wave of British Heavy Metal, is gearing up for its next full‑length record after the February 2025 EP "Can’t Take Away The Fire." Bassist‑vocalist John Gallagher says the EP already outlines the sonic direction—more intense, melodic, and heavier—while the band has a full catalog of written material. Recording is slated for July‑August 2026, and the group intends to test new songs on the tail end of its spring 2026 North American tour, gathering live feedback before finalizing the tracklist.

The album’s timeline intersects with a series of health setbacks that have tested the trio’s resilience. John Gallagher underwent emergency brain surgery in 2025, spending two weeks in intensive care and now remains on anti‑seizure medication while regaining fine‑motor control. Guitarist Mark Gallagher also faced ankle and knee replacements, surgeries that were planned but required extensive rehabilitation. Both members report steady progress, and their recovery narratives have become part of the band’s promotional narrative, underscoring a comeback ethos. Their willingness to share these struggles publicly has resonated with fans and adds authenticity to the upcoming release.

From a business perspective, Raven’s new record and the planned 2027 world tour represent a significant revenue opportunity for both the band and its label, Silver Lining Music. The metal market has shown robust streaming growth, and legacy acts that combine fresh material with extensive touring often outperform newer entrants in ticket sales. By leveraging the EP’s momentum and the human‑interest angle of the members’ recoveries, the band can generate heightened media coverage, pre‑order spikes, and premium ticket packages, reinforcing its position in the evolving heavy‑metal landscape.